[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335437-105":59,"doc-detail-335437-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","genetic-evidence-supporting-the-causal-role-of-25-hydroxyvitamin-d-levels-in-the-prognosis-of-er-breast-cancer-a-mendelian-randomization-study","Genetic evidence supporting the causal role of 25-hydroxyvitamin D levels in the prognosis of ER− breast cancer - A Mendelian randomization study","","This study investigates the causal link between serum 25-hydroxyvitamin D (25(OH)D) levels and breast cancer prognosis across estrogen receptor (ER) statuses using Mendelian randomization. Summary genetic data for 25(OH)D were drawn from a GWAS of 441,291 individuals and breast cancer outcomes from the Breast Cancer Association Consortium. Two-sample MR via inverse variance weighting found no association overall or in ER+ disease, while 25(OH)D showed a protective relationship in ER− breast cancer. Sensitivity tests showed no heterogeneity or horizontal pleiotropy, and multivariable MR adjusting for triglycerides, cholesterol, and BMI preserved and strengthened the ER− effect.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/genetic-evidence-supporting-the-causal-role-of-25-hydroxyvitamin-d-levels-in-the-prognosis-of-er-breast-cancer-a-mendelian-randomization-study/335437/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/genetic-evidence-supporting-the-causal-role-of-25-hydroxyvitamin-d-levels-in-the-prognosis-of-er-breast-cancer-a-mendelian-randomization-study/335437.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What genetic approach was used to test the causal role of 25(OH)D in breast cancer prognosis?","Question",{"text":113,"@type":114},"The study used Mendelian randomization based on GWAS summary statistics for 25(OH)D and breast cancer data from the Breast Cancer Association Consortium.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How did 25(OH)D levels relate to prognosis in overall and ER+ breast cancer?",{"text":118,"@type":114},"Two-sample MR showed no association between 25(OH)D levels and prognosis in overall breast cancer or in ER+ breast cancer.",{"name":120,"@type":111,"acceptedAnswer":121},"What was the finding for ER− breast cancer prognosis after sensitivity and multivariable analyses?",{"text":122,"@type":114},"25(OH)D levels were protective in ER− breast cancer (including multivariable MR adjusting for triglycerides, cholesterol, and BMI), and sensitivity analyses did not indicate heterogeneity or horizontal pleiotropy.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},335437,1790187461,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":29,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","®  \n Observational Study   \nGenetic evidence supporting the causal role of 25-hydroxyvitamin D levels in the prognosis of ER− breast cancer  \nA Mendelian randomization study  \nShang Wu, MSa ,b , Xin-Di Ma, MSa ,b , Xiang-Mei Zhang, MD, PhDb ,c , Chao Shi, MSa ,b , Kai-Ye Du, MSb ,d , Yun-Jiang Liu, MD, PhDa ,b ,*  \n\n| Abstract\u003Cbr>This study aims to investigate the connection between 25-hydroxyvitamin D (25(OH)D) levels and the prognosis of breast cancer with various estrogen receptor (ER) statuses. The summary statistics of 25(OH)D levels was obtained from a GWAS of 441,291 individuals and the information of breast cancer was collected from the Breast Cancer Association Consortium. We analyzed the causal association between 25(OH)D levels and breast cancer prognosis using a number of approaches, including inverse variance weighting (IVW) . The heterogeneity test was performed using Cochran Q test. IVW, Mendelian randomization (MR)-Egger, and MR Pleiotropy RESidual Sum and Outlier methods were used for sensitivity analysis. In addition, a multivariate MR adjusted for total triglycerides, total cholesterol, and body mass index was used for further analysis. Two-sample MR results showed that 25(OH)D levels were not associated with prognosis in overall breast cancer (odds ratio [OR] = 0.93, 95% confidence interval [CI] = 0.73–1. 19, IVW exam) and estrogen receptor positive (ER+) breast cancers (OR = 1. 12, 95% CI = 0.77–1.63, IVW exam) and were protective associated with prognosis in estrogen receptor negative (ER−) breast cancers (OR = 0.55, 95% CI = 0.34– 0.87, IVW exam) . Sensitivity analysis did not observe the presence of heterogeneity and horizontal pleiotropy. In multivariate MR analysis, after adjusting for total triglycerides, total cholesterol, and body mass index, the correlation between the protective relationship between 25(OH)D levels and the prognosis for ER− breast cancer remained and became increasingly significant (OR = 0.51, 95% CI = 0.31–0.83, P = .007) . This study demonstrated a protective relationship between 25(OH)D levels and the prognosis of ER− breast cancer, but there was no connection between 25(OH)D levels and the prognosis of ER+ breast cancer. |\n| --- |\n| Abbreviations: 25(OH)D = 25-hydroxyvitamin D , BMI = body mass index, CI = confidence interval , ER = estrogen receptor, ER+ = estrogen receptor positive, ER− = estrogen receptor negative, IVs = instrumental variables, IVW = inverse variance weighting, LD = distance’s length, MR = Mendelian randomization, MR-PRESSO = MR Pleiotropy RESidual Sum and Outlier, OR = odds ratio, SNPs = single nucleotide polymorphisms. |\n| Keywords: breast cancer, estrogen receptor, genetics, 25-hydroxyvitamin D, Mendelian randomization study |\n\n1. Introduction  \nAs the most frequent cancer among women diagnosed worldwide, breast cancer has overtaken lung cancer. There will be 690,000 fatalities from breast cancer and 2.3 million new cases globally in 2020, putting women’s physical and mental health at significant danger.[1,2] Due to medication resistance and metastasis, some breast cancer patients still have unfavorable prognoses despite the fast advancements in treatment.[3,4] Therefore, additional predictors are required to estimate the outcome of  \nvarious breast cancer patients and assist patients in developing individualized breast cancer treatment plans.[5,6]  \nSerum levels of 25-hydroxyvitamin D (25(OH)D), a hormone precursor that regulates calcium homeostasis, are thought to be the most accurate measure of vitamin D status.[7] Not only does vitamin D have effects on bones, but its various anticancer effects are being discovered,[8,9] and these findings provide theoretical support for the association between vitamin D and cancer incidence and survival.[10] Previous studies have  \nSWandX-DM contributed equally to this work.  \nThis research was funded by Natural Science Foundation of Hebei Province, No. H2023206441 and Beijing-Tianjin-Hebei Basic Research Cooperatio","cbCaieMcSmrZkKLz","https://ap.wps.com/l/cbCaieMcSmrZkKLz","pdf",964943,"English","# Abstract\n## Introduction\n## Abbreviations\n## Keywords","[{\"question\":\"What genetic approach was used to test the causal role of 25(OH)D in breast cancer prognosis?\",\"answer\":\"The study used Mendelian randomization based on GWAS summary statistics for 25(OH)D and breast cancer data from the Breast Cancer Association Consortium.\"},{\"question\":\"How did 25(OH)D levels relate to prognosis in overall and ER+ breast cancer?\",\"answer\":\"Two-sample MR showed no association between 25(OH)D levels and prognosis in overall breast cancer or in ER+ breast cancer.\"},{\"question\":\"What was the finding for ER− breast cancer prognosis after sensitivity and multivariable analyses?\",\"answer\":\"25(OH)D levels were protective in ER− breast cancer (including multivariable MR adjusting for triglycerides, cholesterol, and BMI), and sensitivity analyses did not indicate heterogeneity or horizontal pleiotropy.\"}]","Genetic evidence supporting the causal role of 25-hydroxyvitamin D levels in the prognosis of ER− breast cancer - A Mendelian randomization study | PDF",1790010997,15]